Obesity Intervention: A New Era Of Discovery And Innovation

Article preview from IN VIVO - January, 2013

Device manufacturers are developing several next-generation devices for the minimally invasive treatment of obesity. Many of these emerging devices not only mimic the restriction and malabsorption mechanisms involved in bariatric surgery, but are also designed to influence the metabolic responses that are key to losing weight, improving outcomes, and impacting chronic disease.

Obesity Intervention: A New Era Of Discovery And Innovation

Article preview from IN VIVO - January, 2013

If necessity is the mother of invention, then it should be no surprise that minimally invasive obesity devices continue to be a hot area for investment, research, and innovation. Obesity is one of the most compelling public health problems today, with nearly two-thirds of US adults and one-third of children either overweight or obese. By 2030, some 42% of all Americans are expected to be obese, up from 36% in 2010. Although the rate of growth in obesity has leveled off for some subpopulations since 2003, the numbers of morbidly obese (BMI [body mass index] > or = 40 kg/m²) continue to grow faster than any other group. Approximately 18 million Americans currently are considered morbidly obese, and experts predict the prevalence of morbid obesity will more than double in the years ahead, increasing from roughly 5% today to 11% over the next two decades.

The economic burden of the obesity epidemic is staggering. Obesity accounts for nearly 21% of overall US health care costs, and the US Centers for Disease Control and Prevention estimates that obesity-related medical care costs alone were $147 billion in 2008. But obesity is not a problem in the US only. According to the World Health Organization, obesity has reached epidemic proportions globally, and today, more than 500 million people worldwide are clinically obese. According to the US Department of Health and Human Services (HHS), the US would save $549.5 billion over the next 20 years if the prevalence of obesity remained at 2010 levels.

Continued...

Purchase this article online as a PDF and receive it immediately via email. Questions? Call (800) 332-2181. 100% Satisfaction Guaranteed.

Plus:

To find out about more about more about Elsevier Business Intelligence's medical device publications and databases, multi-user access and/or advertising with Medical Devices Today, please contact Kristy Kennedy at (480) 985-9512